AUTOLUS THERAPEUTICS - EXPECTS FY2026 AUCATZYL NET PRODUCT REVENUE AT OR EXCEEDING UPPER END OF $150 MILLION FROM PRIOR GUIDANCE 

Reuters · 2d ago

Please log in to view news